Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study

European Journal of Heart Failure

Volumn 19, Issue 3, 2017, Pages 391-400

  Niewinski, Piotr ^a   Janczak, Dariusz ^a   Rucinski, Artur ^a   Tubek, Stanislaw ^a,b   Engelman, Zoar J ^c   Piesiak, Pawel ^b   Jazwiec, Przemyslaw ^a   Banasiak, Waldemar ^a   Fudim, Marat ^d   Sobotka, Paul A ^c,e   Javaheri, Shahrokh ^f,g   Hart, Emma C J ^h   Paton, Julian F R ^h   Ponikowski, Piotr ^a,b  

^a 4TH MILITARY HOSPITAL   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c CIBIEM INC   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f Bethesda North Hospital   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Carotid body; Heart failure; Sympathetic modulation

Indexed keywords

ADULT; ARTERIAL GAS; ARTICLE; CAROTID BODY; CAROTID BODY RESECTION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; EXERCISE TOLERANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOXIA; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; OXYGEN SATURATION; OXYGENATION; PATIENT SAFETY; RESPIRATORY FUNCTION; SYMPATHETIC TONE; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME; TREND STUDY; ADRENERGIC SYSTEM; BLOOD GAS ANALYSIS; HEART FAILURE, SYSTOLIC; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

BLOOD GAS ANALYSIS; CAROTID BODY; EXERCISE TOLERANCE; HEART FAILURE, SYSTOLIC; HUMANS; HYPOXIA; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84988358617     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.641     Document Type: Article

References (38)

1. Giannoni A, Emdin M, Poletti R, Bramanti F, Prontera C, Piepoli M, Passino C. Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne–Stokes respiration and arrhythmias. Clin Sci 2008;114:489–497.
2. Niewinski P, Engelman ZJ, Fudim M, Tubek S, Paleczny B, Jankowska EA, Banasiak W, Sobotka PA, Ponikowski P. Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure. J Card Fail 2013;19:408–415.
3. Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M, Coats AJ. Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Hear J 1997;18:480–486.
4. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF, Coats AJ. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001;104:544–549.
5. Del Rio R, Marcus NJ, Schultz HD. Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 2013;62:2422–2430.
6. Marcus NJ, Del Rio R, Schultz EP, Xia XH, Schultz HD. Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol 2014;592:391–408.
7. Ciarka A, Najem B, Cuylits N, Leeman M, Xhaet O, Narkiewicz K, Antoine M, Degaute JP, van de Borne P. Effects of peripheral chemoreceptors deactivation on sympathetic activity in heart transplant recipients. Hypertension 2005;45:894–900.
8. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard JM, Lambert G, Esler M, Pathak A. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 2012;30:753–760.
9. Floras JS, Ponikowski P. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J 2015;36:1974–1982.
10. Paton JF, Sobotka PA, Fudim M, Engleman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine A V, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 2013;61:5–13.
11. Janssen C, Beloka S, Kayembe P, Deboeck G, Adamopoulos D, Naeije R, van de Borne P. Decreased ventilatory response to exercise by dopamine-induced inhibition of peripheral chemosensitivity. Respir Physiol Neurobiol 2009;168:250–253.
12. Chua TP, Ponikowski PP, Harrington D, Chambers J, Coats AJ. Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart 1996;76:483–489.
13. Winter B. Bilateral carotid body resection for asthma and emphysema. A new surgical approach without hypoventilation or baroreceptor dysfunction. Int Surg 1972;57:458–466.
14. Niewiński P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart EC, Paton JF, Ponikowski P. Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol 2013;168:2506–2509.
15. Niewinski P, Janczak D, Rucinski A, Tubek S, Engelman ZJ, Jazwiec P, Banasiak W, Sobotka PA, Hart ECJ, Paton JFR, Ponikowski P. Dissociation between blood pressure and heart rate response to hypoxia after bilateral carotid body removal in men with systolic heart failure. Exp Physiol 2014;99:552–561.
16. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 2012;101:63–67.
17. Remo BF, Preminger M, Bradfield J, Mittal S, Boyle N, Gupta A, Shivkumar K, Steinberg JS, Dickfeld T. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm 2014;11:541–546.
18. Hart EC, Joyner MJ, Wallin BG, Johnson CP, Curry TB, Eisenach JH, Charkoudian N. Age-related differences in the sympathetic–hemodynamic balance in men. Hypertension 2009;54:127–133.
19. Hart EC, Joyner MJ, Wallin BG, Karlsson T, Curry TB, Charkoudian N. Baroreflex control of muscle sympathetic nerve activity: a nonpharmacological measure of baroreflex sensitivity. Am J Physiol Heart Circ Physiol 2010;298:H816–H822.
20. Nguyen RP, Shah LM, Quigley EP, Harnsberger HR, Wiggins RH. Carotid body detection on CT angiography. Am J Neuroradiol 2011;32:1096–1099.
21. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN, Meta-Analysis Global Group in Chronic Heart Failure. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013;34:1404–1413.
22. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819–823.
23. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Hear J 2001;22:1136–1143.
24. Sinski M, Lewandowski J, Przybylski J, Bidiuk J, Abramczyk P, Ciarka A, Gaciong Z. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res 2012;35:487–91.
25. Paton JF. Convergence properties of solitary tract neurones driven synaptically by cardiac vagal afferents in the mouse. J Physiol 1998;508:237–252.
26. Pyner S. The paraventricular nucleus and heart failure. Exp Physiol 2014;99:332–339.
27. Zoccal DB, Simms AE, Bonagamba LG, Braga VA, Pickering AE, Paton JF, Machado BH. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J Physiol 2008;586:3253–3265.
28. Notarius CF, Morris B, Floras JS. Caffeine prolongs exercise duration in heart failure. J Card Fail 2006;12:220–226.
29. Conde S V, Obeso A, Vicario I, Rigual R, Rocher A, Gonzalez C. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors. J Neurochem 2006;98:616–628.
30. Alves MJ, Rondon MU, Santos AC, Dias RG, Barretto AC, Krieger EM, Middlekauff HR, Negrao CE. Sympathetic nerve activity restrains reflex vasodilatation in heart failure. Clin Aut Res 2007;17:364–369.
31. Vermeire P, de Backer W, van Maele R, Bal J, van Kerckhoven W. Carotid body resection in patients with severe chronic airflow limitation. Bull Eur Physiopathol Respir 1987;23 Suppl 1:165s–166s.
32. Moore DP, Weston AR, Hughes JM, Oakley CM, Cleland JG. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:850–853.
33. Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Thanapiboonpol P, Nakyen S, Udompunturak S. Correlation between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study. J Card Fail 2008;14:687–694.
34. Lugliani R, Whipp BJ, Seard C, Wasserman K. Effect of bilateral carotid-body resection on ventilatory control at rest and during exercise in man. N Engl J Med 1971;285:1105–1111.
35. Nattie E, Li A. Central chemoreceptors: locations and functions. Comp Physiol 2012;2:221–254.
36. Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T. Effects of inhaled carbon dioxide and oxygen on Cheyne–Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999;159:1490–1498.
37. Heusser K, Tank J, Brinkmann J, Menne J, Kaufeld J, Linnenweber-Held S, Beige J, Wilhelmi M, Diedrich A, Haller H, Jordan J. Acute response to unilateral unipolar electrical carotid sinus stimulation in patients with resistant arterial hypertension. Hypertension 2016;67:585–591.
38. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 2011;32:847–855.